January saw 11 new companies reach unicorn status—valued at $1 billion or more—according to Crunchbase data. Notably, five of these newcomers come from the healthcare sector, reflecting a strong focus on innovations in genetic research, drug development, scanning technologies, AI healthcare agents, and home healthcare services.

The remaining six new unicorns span a variety of industries, but most share a connection to artificial intelligence, powering advances across professional services, computer vision, data storage, and space technology.

Among the healthcare highlights:

• Neko Health, a Stockholm-based body-scanning company, raised $260 million and now holds a $1.8 billion valuation.
  
  
• Hippocratic AI, a Palo Alto startup building AI agents for patient assistance, became a unicorn just a year after founding, following a $141 million funding round.
  
  
• Aragen Life Sciences from India secured $100 million to support health science research.
  
  
• Truveta, a Seattle-based genetic database company, raised $320 million.
  
  
• Cera, a London-based in-home healthcare provider, garnered $150 million in combined equity and debt funding.
  
  

In total, seven of the new unicorns are U.S.-based, three are European (from the U.K., Sweden, and Switzerland), and one is from India. This steady flow surpasses last year’s monthly average of nine new unicorns and continues the industry-wide momentum around AI-driven healthcare innovation.